161 related articles for article (PubMed ID: 23422591)
1. Self-assembly of ciprofloxacin and a tripeptide into an antimicrobial nanostructured hydrogel.
Marchesan S; Qu Y; Waddington LJ; Easton CD; Glattauer V; Lithgow TJ; McLean KM; Forsythe JS; Hartley PG
Biomaterials; 2013 May; 34(14):3678-87. PubMed ID: 23422591
[TBL] [Abstract][Full Text] [Related]
2. A photopolymerized antimicrobial hydrogel coating derived from epsilon-poly-L-lysine.
Zhou C; Li P; Qi X; Sharif AR; Poon YF; Cao Y; Chang MW; Leong SS; Chan-Park MB
Biomaterials; 2011 Apr; 32(11):2704-12. PubMed ID: 21257199
[TBL] [Abstract][Full Text] [Related]
3. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
Coban AY; Bayram Z; Sezgin FM; Durupinar B
Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of DNA-porphyrin hybrid molecules for the creation of antimicrobial nanonetwork.
Kumari R; Khan MI; Bhowmick S; Sinha KK; Das N; Das P
J Photochem Photobiol B; 2017 Jul; 172():28-35. PubMed ID: 28514711
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
Gebre-Sealsssie S
Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterisation of flower shaped zinc oxide nanostructures and its antimicrobial activity.
Mohan Kumar K; Mandal BK; Appala Naidu E; Sinha M; Siva Kumar K; Sreedhara Reddy P
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 104():171-4. PubMed ID: 23266691
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of short cationic antimicrobial peptidomimetics containing arginine analogues.
Baldassarre L; Pinnen F; Cornacchia C; Fornasari E; Cellini L; Baffoni M; Cacciatore I
J Pept Sci; 2012 Sep; 18(9):567-78. PubMed ID: 22807132
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity and stability of tingenone derivatives.
Sotanaphun U; Lipipun V; Suttisri R; Bavovada R
Planta Med; 1999 Jun; 65(5):450-2. PubMed ID: 10418334
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic, structure and antimicrobial activity of new Y(III) and Zr(IV) ciprofloxacin.
Sadeek SA; El-Shwiniy WH; Zordok WA; El-Didamony AM
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Feb; 78(2):854-67. PubMed ID: 21208824
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin surf-plexes in sub-micron emulsions: a novel approach to improve payload efficiency and antimicrobial efficacy.
Jain V; Singodia D; Gupta GK; Garg D; Keshava GB; Shukla R; Shukla PK; Mishra PR
Int J Pharm; 2011 May; 409(1-2):237-44. PubMed ID: 21356290
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
15. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
[TBL] [Abstract][Full Text] [Related]
16. Regioselective synthetic approaches towards 1,2,8,9-tetraazadispiro[4.1.4.2]trideca-2,9-dien-6-ones of potential antimicrobial properties.
Girgis AS; Barsoum FF; Samir A
Eur J Med Chem; 2009 Jun; 44(6):2447-51. PubMed ID: 19211175
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
18. Lipid-binding and antimicrobial properties of synthetic peptides of bovine apolipoprotein A-II.
Motizuki M; Itoh T; Satoh T; Yokota S; Yamada M; Shimamura S; Samejima T; Tsurugi K
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):215-21. PubMed ID: 10432319
[TBL] [Abstract][Full Text] [Related]
19. Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus.
Bosso JA; Mauldin PD
Antimicrob Agents Chemother; 2006 Jun; 50(6):2106-12. PubMed ID: 16723572
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
